HBI Deals+Insights / M&A/IPOs

Global private equity firm Orbimed looks set to invest in Indian diagnostics

The global private equity firm, Orbimed, which invests in healthcare from early stage to multinationals, is making a US$40m bet on Indian diagnostics. It’s targeted Suraksha Diagnostics of Kolkata, and the deal is likely to be announced soon.

We would welcome your thoughts on this story. Email your views to Claude Risner or call 0207 183 3779.